Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice.
A series of transgenic mice was produced by microinjection of a segment of DNA, containing 460 base pairs of the phosphoenolpyruvate (P-enolpyruvate) carboxykinase promoter-regulatory region ligated to the bovine growth hormone structural gene, into the male pronucleus of fertilized mouse eggs. Founder animals which contained the gene were selected for further analysis and for breeding. The concentration of bovine growth hormone in the serum of animals which were shown to contain the gene ranged from a low of 5 ng/ml serum to approximately 2300 ng/ml serum. Mice with high levels of bovine growth hormone had growth rates double that of their litter mates which did not contain the transgene. The transgene was expressed only in the liver and kidney of the animals studied, and the level of specific mRNA for bovine growth hormone in these tissues could be regulated by diet in a manner similar to the endogenous P-enolpyruvate carboxykinase gene. Feeding the animals a diet high in carbohydrate for 1 week caused a 90% decrease in the concentration of bovine growth hormone in the blood, suggesting that the expression of the chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene is sensitive to insulin. When the same animals were then refed a diet high in protein, but devoid of carbohydrate, the concentration of bovine growth hormone in their blood was induced 30-fold within a week. The administration of dibutyryl cyclic AMP to the transgenic mice caused a 2-fold induction in the level of bovine growth hormone in the serum within 90 min. Thus the region between -460/+73 in the P-enolpyruvate carboxykinase promoter-regulatory region contains sequences which can direct the tissue-specific expression, as well as hormonal and dietary responsiveness, of a linked structural gene.
McGrane
M M
MM
Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
de Vente
J
J
Yun
J
J
Bloom
J
J
Park
E
E
Wynshaw-Boris
A
A
Wagner
T
T
Rottman
F M
FM
Hanson
R W
RW
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D003994:Bucladesine / Q000494:pharmacology; D002678:Chimera; D004262:DNA Restriction Enzymes / Q000378:metabolism; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004044:Dietary Proteins / Q000008:administration & dosage; D005260:Female; D005786:Gene Expression Regulation; D013006:Growth Hormone / Q000235:genetics*; D006238:Haploidy; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D010375:Pedigree; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000235:genetics*; D010957:Plasmids; D011994:Recombinant Proteins / Q000032:analysis
D004040:Dietary Carbohydrates; D004044:Dietary Proteins; D011994:Recombinant Proteins; D003994:Bucladesine; D013006:Growth Hormone; D004262:DNA Restriction Enzymes; D010729:Phosphoenolpyruvate Carboxykinase (GTP)